Psychiatric medication management is not a simple matter of writing prescriptions and monitoring side effects; it involves tracking the complex, often unpredictable interactions between a patient’s neurobiological profile, life circumstances, and a pharmacological regimen that may include multiple agents, each with its own mechanism, timeline, and tolerability considerations. At Minnesota Ketamine & Wellness Institute, we offer Medication Management in Minneapolis as a dedicated service, providing patients with advanced practice nursing expertise alongside our broader spectrum of treatment options including ketamine therapy and SPRAVATO®. For many of our patients, medication management is the connective tissue that holds a multidisciplinary treatment plan together.
What Medication Management Actually Means
Medication management in the context of a mental health specialty practice means something specific. It is not a rushed seven-minute appointment. It means a systematic, clinically rigorous evaluation of what medications a patient is currently taking, what has been tried in the past, what has worked, what has not, and why. It means understanding the clinical rationale behind each agent in a regimen, identifying potential drug interactions, and having an honest conversation about side effects that may be silently eroding a patient’s quality of life. Most importantly, it means being willing to change course when a current approach is not working — not out of impatience, but out of clinical precision and respect for the patient’s time and suffering.
For patients who have been managing depression, anxiety, or PTSD through a primary care physician or a busy general psychiatry practice, the depth of medication review that a specialty mental health practice can offer may feel genuinely different. We have the time, the clinical framework, and the specific expertise in treatment-resistant conditions to take a thorough inventory of what has been tried, apply current evidence to what the next step should be, and monitor changes closely. This is particularly valuable in the context of treatment-resistant depression, where patients may have been through multiple medication trials without adequate systematic evaluation of what was missing from each attempt. To better understand what medication management means in mental health, it helps to see how a specialty practice differs from a standard primary care setting.
The Advantage of a CRNA-Led Pharmacological Approach
Christy Hatcher’s advanced practice nursing background provides a specific lens for medication management. As a CRNA, Christy brings deep pharmacological training — understanding mechanisms of action, drug-drug interactions, pharmacokinetics, and the physiological parameters that determine dosing safety — that is directly relevant to complex psychopharmacological management. Advanced practice nurses who specialize in psychiatric care bring a clinical orientation that integrates both the biomedical and holistic dimensions of a patient’s health, attentive to sleep, nutrition, trauma history, and relational factors alongside the pharmacological picture. Our team’s combined experience of over 40 years in mental health and anesthesia services means that Medication Management at our institute benefits from a depth of consultation resources uncommon in smaller practices.
Medication Management as a Bridge to SPRAVATO® and Ketamine
One of the most important roles Medication Management plays in our practice is as a bridge to and from ketamine therapy and SPRAVATO®. SPRAVATO® is our primary recommended option for patients who meet criteria for treatment-resistant depression — it is FDA-approved, covered by most major insurance plans for eligible patients, and requires an optimized oral antidepressant alongside it. Managing that combination, ensuring the oral antidepressant component of the regimen is appropriate and well-tolerated, and monitoring the overall pharmacological picture is exactly the kind of clinical work that Medication Management is designed to do.
Some patients come to us specifically for infusion or SPRAVATO® treatment and need a medication review to ensure their current regimen is compatible with ketamine pharmacology. Certain medications — particularly benzodiazepines, which affect GABA signaling — may blunt ketamine’s efficacy; others require dose adjustments during a ketamine course. We evaluate every patient’s medication list carefully before beginning infusions, and this review is a clinical requirement, not a formality. For patients who respond well to ketamine therapy and want to consider whether their long-term maintenance medication regimen needs adjustment in light of that response, our Medication Management service provides ongoing clinical support.
SPRAVATO® must always be administered in a certified healthcare setting under direct clinical supervision, and every SPRAVATO® session at our institute occurs within the full context of a medication management framework, not in isolation. Our institute also holds a VA Community Care Network (VCA) contract, and veterans referred through that program who are receiving ketamine infusions at our clinic benefit from the same integrated medication oversight — ensuring their broader psychiatric regimen supports, rather than interferes with, their treatment. Patients curious about how a medication management program works in practice will find that the process is highly individualized and clinically driven from start to finish.
Addressing Common Barriers
One barrier we address with patients considering Medication Management is the sense that seeking another medication review means starting over from scratch. We understand why this feels discouraging, particularly for patients who have been through multiple treatment trials. Our intake process is designed to treat prior treatment history as valuable clinical data rather than evidence of failure. Every medication that did not work tells us something about what to try next, and every side effect that drove discontinuation gives us information about a patient’s individual neurobiological profile. We build on what came before rather than discarding it.
The second barrier is uncertainty about what Medication Management actually involves practically — how often appointments are needed, what the process looks like, and whether it requires a full transfer of prescribing care. We are flexible on these logistics, and we encourage every patient to have a direct conversation with us about how the service would function given their current care team and preferences. Some patients want our team to assume primary medication oversight; others prefer a consultative relationship in which we advise while their existing prescriber continues to manage day-to-day prescriptions. We can accommodate both approaches, and we communicate with referring and existing providers as needed with patient consent. Results vary by individual; discuss with your provider what level of medication management involvement makes sense for your situation.
Integrating Medication Management with ketamine therapy or ketamine-assisted psychotherapy (KAP) is one of the distinctive features of our institute’s model. We do not offer ketamine in a vacuum. We treat it as one component of a comprehensive mental health plan that includes thorough pharmacological oversight, licensed psychological support, and the kind of whole-person attention that produces durable rather than transient change. For patients researching their options, our post on the first month of ketamine therapy in Minnesota offers a candid look at what to expect when combining treatments.
Frequently Asked Questions
What conditions does Medication Management at your institute address? Our Medication Management service focuses on psychiatric conditions including treatment-resistant depression, major depressive disorder, anxiety disorders, PTSD, OCD, and bipolar depression. We address these in the context of our broader treatment offerings — ketamine therapy, SPRAVATO®, and KAP — and can evaluate whether a patient’s current pharmacological regimen is well-positioned to support or be combined with those treatments.
Do I have to be a ketamine patient to receive Medication Management services? No. Patients can come to us specifically for medication management without receiving ketamine therapy or SPRAVATO®. However, for many patients, the combination of medication optimization and infusion or esketamine treatment provides more comprehensive benefit than either alone. We discuss both options during the initial consultation.
Will you work with my existing psychiatrist or prescriber? Yes. We can operate in a consultative capacity, providing clinical recommendations to your existing provider, or we can assume primary prescribing responsibility — whichever arrangement best serves your care. Patient consent and clear communication with your current team guide how we structure the collaborative relationship.
How does medication management relate to SPRAVATO® treatment? SPRAVATO® is FDA-approved for use as an adjunct to oral antidepressants, not as a standalone treatment. Managing the oral antidepressant component of a SPRAVATO® regimen — ensuring it is appropriate, optimally dosed, and well-tolerated — is a core function of our Medication Management service for SPRAVATO® patients. Discuss with your provider how your current antidepressant regimen will be evaluated before beginning SPRAVATO®.
How often are Medication Management appointments? Frequency depends on clinical need. Newly initiated regimens or significant medication changes require closer follow-up — often every two to four weeks initially. Stable patients may be seen less frequently. We establish a monitoring schedule based on each patient’s clinical situation during the intake evaluation.
Key Takeaways
- Medication Management at Minnesota Ketamine & Wellness Institute brings advanced pharmacological training from a CRNA background to complex psychiatric cases
- The service is particularly valuable for patients with treatment-resistant conditions who have a complex prior medication history
- SPRAVATO® is our primary recommended option for TRD — FDA-approved and covered by most major insurance plans for eligible patients — and Medication Management ensures the required oral antidepressant component is optimized alongside it
- Veterans receiving ketamine infusions through the VA Community Care Network (VCA) contract benefit from the same integrated medication oversight
- Results vary by individual; discuss your medication history and treatment goals with your provider to develop a personalized plan
Mental health treatment works best when the pharmacological, psychological, and clinical dimensions are all attended to with equal care. At Minnesota Ketamine & Wellness Institute, our Medication Management service is designed to provide that kind of comprehensive, individualized oversight — whether as a standalone service or as part of a combined treatment plan that includes ketamine therapy or SPRAVATO®. If you have been managing your mental health with medications that are not working as well as they should, we invite you to schedule a consultation with our team.
References
American Psychiatric Association — https://www.psychiatry.org/patients-families/depression/what-is-depression
National Alliance on Mental Illness — https://www.nami.org/About-Mental-Illness/Treatments/Mental-Health-Medications
Janssen Pharmaceuticals (SPRAVATO® Prescribing Information) — https://www.spravato.com/
American Association of Nurse Practitioners — https://www.aanp.org/
About Christy Hatcher, MSN, APRN, CRNA
Christy Hatcher, MSN, APRN, CRNA is the owner and lead provider at Minnesota Ketamine & Wellness Institute. She specializes in ketamine infusions as an alternative or adjunct treatment for depression, anxiety, PTSD, and suicidal ideation. The Institute offers a multidisciplinary team with over 40 years of combined experience in mental health and anesthesia services, including therapists who are Certified Clinical Trauma Professionals, Somatic Psychedelic Facilitators, and licensed clinical social workers certified in psychedelic-assisted therapy. The clinic integrates ketamine-assisted psychotherapy (KAP) and integration therapy alongside infusion services, holds a VA Community Care Network (VCA) contract for eligible veterans, and offers SPRAVATO® as its primary FDA-approved, insurance-covered option for treatment-resistant depression.
Medical Disclaimer
The content of this article is provided by Minnesota Ketamine & Wellness Institute for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Individual results vary. All medication management decisions should be made in consultation with a qualified healthcare provider who has reviewed your full clinical history. Always discuss treatment options, risks, and benefits with your provider before making any changes to your medications.